Following adults with suspected or confirmed blood clots in veins and lungs
Follows adults with suspected or diagnosed venous thromboembolism to improve diagnosis and care.
Key facts
- Who runs it
- Johannes Gutenberg University Mainz
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE
- Status
- Recruiting
- People taking part
- 2,000 people, planned
- Started
- Apr 2013
- Expected to end
- Jul 2030
- Type of study
- Observational, 3 groups
- Record updated
- 17 June 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a suspected blood clot in the lung (pulmonary embolism) or in a deep vein (deep vein thrombosis), or with a vein clot found by chance (VTE). It is an observational study that collects data and samples.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- One of three groups: doctors suspect a sudden (acute) lung clot, with or without a leg vein clot; doctors suspect a sudden deep vein clot without lung clot symptoms; or a vein clot was found by chance.
Main reasons for not taking part
- People younger than 18 years cannot join.
- People who do not give written consent cannot join.
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Age ≥18 years and Informed written consent
- Clinical condition:; Cohort 1: Clinical suspicion of acute PE (with or without DVT); Cohort 2: Clinical suspicion of acute DVT (without symptomatic PE); Cohort 3: Incidentally diagnosed VTE
This trial is currently available in Germany.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Venous thromboembolism (VTE) with its two clinical manifestations deep vein thrombosis (DVT) and pulmonary embolism (PE) is a life-threatening disease that is associated with considerable morbidity and mortality. The incidence of VTE increases with age and it - as the third most common cardiovascular disease after ischemic heart disease and stroke - represents an important public health problem in industrialized countries with several aspects in need to be addressed.
Read full original descriptionShow less
VTEval Project includes three long-term prospective observational studies to evaluate and improve VTE diagnostics and management, treatment and outcome. The aims of the project include a systematic assessment of VTE, i.e. disease status (symptoms, clinical and subclinical aspects) and risk profiles (classic, psychosocial and environmental factors), using a system-oriented approach. VTEval collects three large prospective cohorts of patients with suspected and incident VTE consisting of individuals with a clinical suspicion of acute PE, individuals with a clinical suspicion of acute DVT, and individuals with incidental diagnosis of VTE).
The standardized and harmonized data acquisition of the study establishes a sustainable resource for comprehensive research on VTE, thus providing the basis for both short- and long-term analysis.
The 3 groups in the trial
- Cohort 1: Suspect of Pulmonary Embolism (PE)
- Cohort 2: Suspect of Deep Vein Thrombosis (DVT)
- Cohort 3: Incidental Venous Thromboembolism (VTE)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- VTEval Project - Three Observational, Prospective Cohort Studies Including Biobanking to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in Venous Thromboembolism
- Plain-language title
- Following adults with suspected or confirmed blood clots in veins and lungsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Publications
- Record updated
- 17 June 2024